AU2001290744A1 - Method of identifying putative antibiotic resistance genes - Google Patents

Method of identifying putative antibiotic resistance genes

Info

Publication number
AU2001290744A1
AU2001290744A1 AU2001290744A AU9074401A AU2001290744A1 AU 2001290744 A1 AU2001290744 A1 AU 2001290744A1 AU 2001290744 A AU2001290744 A AU 2001290744A AU 9074401 A AU9074401 A AU 9074401A AU 2001290744 A1 AU2001290744 A1 AU 2001290744A1
Authority
AU
Australia
Prior art keywords
antibiotic resistance
resistance genes
identifying putative
putative antibiotic
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290744A
Other languages
English (en)
Inventor
Miriam Barlow
Barry G. Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Publication of AU2001290744A1 publication Critical patent/AU2001290744A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001290744A 2000-09-11 2001-09-11 Method of identifying putative antibiotic resistance genes Abandoned AU2001290744A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23190400P 2000-09-11 2000-09-11
US60231904 2000-09-11
PCT/US2001/028335 WO2002022876A1 (fr) 2000-09-11 2001-09-11 Methode d'identification de genes putatifs d'antibioresistance

Publications (1)

Publication Number Publication Date
AU2001290744A1 true AU2001290744A1 (en) 2002-03-26

Family

ID=22871090

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290744A Abandoned AU2001290744A1 (en) 2000-09-11 2001-09-11 Method of identifying putative antibiotic resistance genes

Country Status (4)

Country Link
US (1) US7125662B2 (fr)
EP (1) EP1322786A4 (fr)
AU (1) AU2001290744A1 (fr)
WO (1) WO2002022876A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2387173A (en) * 2002-03-05 2003-10-08 Arrow Therapeutics Ltd Transposon
WO2011137368A2 (fr) 2010-04-30 2011-11-03 Life Technologies Corporation Systèmes et méthodes d'analyse de séquences d'acides nucléiques
US9268903B2 (en) 2010-07-06 2016-02-23 Life Technologies Corporation Systems and methods for sequence data alignment quality assessment
CN108491692B (zh) * 2018-03-09 2023-07-21 中国科学院生态环境研究中心 一种构建抗生素抗性基因数据库的方法
CN113293201A (zh) * 2021-06-23 2021-08-24 清华大学深圳国际研究生院 一种新型氯霉素抗性基因的快速定量检测方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935340A (en) * 1985-06-07 1990-06-19 Eli Lilly And Company Method of isolating antibiotic biosynthetic genes
CA2131369A1 (fr) 1992-03-02 1993-09-16 Stanley Falkow Microorganismes a caractere invasif attenue
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6130036A (en) 1994-02-18 2000-10-10 University Of Washington Methods and compositions for screening for anti-AIDS drugs
US6063562A (en) 1994-09-16 2000-05-16 Sepracor, Inc. In vitro method for predicting the evolutionary response of HIV protease to a drug targeted thereagainst
US5766842A (en) 1994-09-16 1998-06-16 Sepracor, Inc. In vitro method for predicting the evolutionary response of a protein to a drug targeted thereagainst
EP1051484A1 (fr) 1998-01-30 2000-11-15 Sepracor, Inc. Proteines de fusion regulatrices de genes et leurs procedes d'utilisation pour determiner la resistance d'une proteine a un medicament dirige contre elle
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof

Also Published As

Publication number Publication date
EP1322786A1 (fr) 2003-07-02
US20040197776A1 (en) 2004-10-07
EP1322786A4 (fr) 2005-11-16
WO2002022876A1 (fr) 2002-03-21
US7125662B2 (en) 2006-10-24

Similar Documents

Publication Publication Date Title
AU2001234608A1 (en) Methods for analysis of gene expression
AU2002232393A1 (en) Methods for identifying genes associated with diseases or specific phenotypes
AU2001290309A1 (en) Method of diagnosing nephropathy
AU2001271720A1 (en) Methods and compositions for determining gene function
AU5215601A (en) Inflammation-related gene
AU2002339960A1 (en) Devices and methods for detecting genetic sequences
AU2001281633A1 (en) Detection method
AU2001271841A1 (en) Methods for identifying combinations of drugs
AU6387000A (en) Serial analysis of genetic alterations
AU2001278813A1 (en) Multiplex pcr method and kit and oligonucleotides for detection and identification of mycobacteria using the multiplex pcr method
AU2001233176A1 (en) Resistance sequences and uses thereof
AU2002222618A1 (en) Method of analyzing gene expression
AU2001242625A1 (en) Gene sequence
AU2002311780A1 (en) Methods for isolating genes from microorganisms
AU2001290744A1 (en) Method of identifying putative antibiotic resistance genes
AU2002213164A1 (en) Detection of dna damage
AU2001229530A1 (en) Detection of fermentation-related microorganisms
AU2001240103A1 (en) Reproduction-specific genes
AU2001264247A1 (en) GASC1 gene
WO2001098454A8 (fr) Sequences d'adn humain
AU2002221104A1 (en) Method of detecting relation between genes
AUPQ749100A0 (en) New epilespy gene
AU2001285155A1 (en) Polymorphic dna fragments and uses thereof
AU3529699A (en) Plant-derived resistance gene
AU2001292468A1 (en) Methods and means of rna analysis